All People News articles – Page 10
-
NewsUK’s first water monitoring center launched to act as early-warning system for disease outbreaks and community health
The University of Bath is launching the UK’s first early-warning public health surveillance system based on detecting tiny traces of chemicals and biological markers found in water.
-
NewsSecurity-relevant research in times of geopolitical polarisation: report
A new report on security-relevant research - including research into pathogens - notes a change within the scientific system due to increased national security interests.
-
NewsBfR organises three-day conference on food microbiology
The German Federal Institute for Risk Assessment, the German Society for Microbiology and Hygiene (DGHM) and the Association for General and Applied Microbiology (VAAM) are inviting researchers to the 19th Food Microbiology Conference in Berlin from 1 to 3 April.
-
NewsMeasles elimination versus eradication: The difference explained
As of March 13, the CDC has confirmed 301 cases of measles as well as the death of a child in Texas. Amira Roess, an epidemiologist and professor of global health, clarifies the benefits of vaccinating children and adolescents against measles.
-
NewsUKHSA highlights pathogens of greatest risk to public health in bid to boost preparedness
The UK Health Security Agency (UKHSA) has today published its view on the pathogen families that could pose the greatest risk to public health, in a bid to focus and guide preparedness efforts against these threats.
-
NewsInfluenza of avian origin confirmed in a sheep in Yorkshire
The UK’s Chief Veterinary Officer has confirmed a case of influenza of avian origin (H5N1) in a single sheep in Yorkshire following repeat positive milk testing.
-
NewsMcMaster leads Canada’s first-ever guidelines for Post COVID-19 Condition
A team of experts from McMaster University has led the creation of Canada’s first-ever comprehensive guidelines for diagnosing, managing, preventing, and treating post COVID-19 condition (PCC), more commonly known as long COVID.
-
NewsAMI leaders join International Microbiome Meeting in San Diego
Leading scientists from around the world recently convened at the Center for Microbiome Innovation’s International Microbiome Meeting (CIMM) at the Scripps Institution of Oceanography in San Diego.
-
NewsWHO calls for urgent action to address worldwide disruptions in tuberculosis services
Since World Tuberculosis Day is only days away, World Health Organization addresses the current challenges faced by countries in TB responses. They urgently call for an united global effort to combat the deadly disease and safeguard the public health from the devastating consequences.
-
NewsLong COVID could be causing huge economic burden annually
Behind the healthcare burden from long COVID, a study has also uncovered the economic burden of those who are more likely to suffer from long COVID through a computer simulation model of long COVID probabilities and the accompanied productivity loss.
-
NewsLead science organizations affirm vaccine safety amid rising misinformation and declining trust
A unified statement, issued by a coalition of leading scientific and medical organizations, addresses the rise in vaccine misinformation and a decline in trust of science, amidst the outbreaks of preventible infectious diseases. It reassures the current concerns on vaccine safety and emphasizes the importance of vaccinations in public health.
-
NewsProfessor Sabiha Essack wins Christiana Figueres Policy to Practice Award
Professor Sabiha Essack, the South African Research Chair in Antibiotic Resistance and One Health, Professor in Pharmaceutical Sciences at the University of KwaZulu-Natal, has been awarded the Christiana Figueres Policy to Practice Award.
-
NewsAfro-Caribbean Commercial Science Network (ACCSN) named as winner of Dorothy Jones Diversity and Inclusion Achievement Award 2024
The Afro-Caribbean Commercial Science Network (ACCSN), founded by Daniel Similaki, has been named as this year’s winner of the Dorothy Jones Diversity and Inclusion Achievement Award 2024.
-
NewsNIH-sponsored trial of Lassa vaccine opens
A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
-
News2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
The 13th Gut Microbiota for Health World Summit, taking place March 15-16 in Washington, D.C., will reveal how cutting-edge research on gut microbiome science is being applied to clinical practice.
-
NewsProfessor investigates how symbiotic groups - like corals and biofilms - can behave like single organisms
UNCG philosopher of biology Dr. Derek Skillings is the lead investigator on a new, three-year, $600,000 grant from the John Templeton Foundation for a study of the emergence and evolution of goal-directed behavior in collective entities.
-
NewsSwRI receives $3 million NASA astrobiology grant to study microbial life in Alaska’s arctic sand dunes
Southwest Research Institute (SwRI) has received a three-year, $2,999,998 million grant from NASA to identify and characterize life and its biosignatures in frozen sand dunes in Alaska, under conditions similar to dune fields on early Mars and Saturn’s moon Titan. Source: Southwest Research Institute The Great Kobuk Sand ...
-
NewsInhaled COVID vaccine study begins recruitment for phase-2 human trials
Researchers have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. Findings from the phase-1 trial indicate that the vaccine is more effective at inducing immune responses than traditional injected vaccines are.
-
NewsThe Institut Pasteur joins the Stand Up for Science community
Echoing the Stand Up for Science Day initiated in the United States, scientists and academics in France are calling for mobilization actions in every city.
-
NewsEradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25.